Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis

NCT06461299 is registered in ClinicalTrials.gov with The Dermatology Institute of Boston as lead sponsor.

NCT NCT06461299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06461299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis
Lead sponsor
The Dermatology Institute of Boston
Phase
Phase 4
Overall status
Completed
Start date
July 17, 2023
Completion date
March 31, 2024
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

perioral dermatitis